Details for New Drug Application (NDA): 016466
✉ Email this page to a colleague
NDA 016466 describes ARISTOSPAN, which is a drug marketed by Anika Theraps Inc and is included in one NDA. Additional details are available on the ARISTOSPAN profile page.
The generic ingredient in ARISTOSPAN is triamcinolone hexacetonide. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone hexacetonide profile page.
The generic ingredient in ARISTOSPAN is triamcinolone hexacetonide. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone hexacetonide profile page.
Summary for 016466
| Tradename: | ARISTOSPAN |
| Applicant: | Anika Theraps Inc |
| Ingredient: | triamcinolone hexacetonide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
